Lamivudine Zidovudine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Direct Rx. The primary component is Lamivudine; Zidovudine.
| Product ID | 61919-061_35e360f7-dbde-5dd9-e054-00144ff88e88 |
| NDC | 61919-061 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lamivudine Zidovudine |
| Generic Name | Lamivudine Zidovudine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-01-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202418 |
| Labeler Name | Direct Rx |
| Substance Name | LAMIVUDINE; ZIDOVUDINE |
| Active Ingredient Strength | 150 mg/1; mg/1 |
| Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2015-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA202418 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-01 |
| Ingredient | Strength |
|---|---|
| LAMIVUDINE | 150 mg/1 |
| SPL SET ID: | 77eccfa0-c03c-49a3-bfa7-f31888d77161 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |